| Only Phase II and III\ | |
| Size reduced to 5k samples | |
| # Contains: | |
| - TRIAL NAME | |
| - BRIEF | |
| - DRUG USED | |
| - DRUG CLASS | |
| - INDICATION | |
| - TARGET | |
| - THERAPY | |
| - LEAD SPONSOR | |
| - CRITERIA | |
| - PRIMARY OUTCOME | |
| - SECONDARY OUTCOME 1 | |
| Only Phase II and III\ | |
| Size reduced to 5k samples | |
| # Contains: | |
| - TRIAL NAME | |
| - BRIEF | |
| - DRUG USED | |
| - DRUG CLASS | |
| - INDICATION | |
| - TARGET | |
| - THERAPY | |
| - LEAD SPONSOR | |
| - CRITERIA | |
| - PRIMARY OUTCOME | |
| - SECONDARY OUTCOME 1 | |